Search General Info
Search Education
Search Partnering Companies

Patrik De Haes, MD

LEUVEN, Belgium
Dr Patrik De Haes has over 25 years of experience in the global healthcare industry, covering product development, marketing and general management. Before being appointed CEO of Oxurion (previously ThromboGenics) in 2008, Patrik was Head of Roche's Global Insulin Infusion business. Prior to this, he was President and CEO of Disetronic Medical Systems Inc, a medical device company based in Minneapolis, USA. He also led the global development and commercialization of the first biotech product at Sandoz Pharma
(now Novartis) in Switzerland. As past Chairman of FlandersBio, Patrik is an active member of the local and regional biotech and life sciences community in Belgium. Patrik is also Executive Chairman of Oncurious NV, an emerging oncology company
co-created by Oxurion NV and VIB life sciences. Patrik holds a degree in Medicine from the University of Leuven.
Speaking In
[Available On-Demand]
Oxurion (Euronext Bxls: OXUR) is developing next generation therapies for retinal vascular disease,…